Crude and adjusted HRs (95% CIs) for ischaemic heart disease in the nephrolithiasis and control groups
| Characteristics | HRs for ischaemic heart disease | |||
| Crude* | P value | Adjusted*† | P value | |
| Total participants (n=95 515) | ||||
| Nephrolithiasis | 1.29 (1.23 to 1.36) | <0.001‡ | 1.24 (1.18 to 1.31) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age <60 years, men (n=44 595) | ||||
| Nephrolithiasis | 1.29 (1.19 to 1.39) | <0.001‡ | 1.24 (1.14 to 1.34) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age <60 years, women (n=22 140) | ||||
| Nephrolithiasis | 1.51 (1.34 to 1.70) | <0.001‡ | 1.43 (1.27 to 1.62) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age ≥60 years, men (n=16 920) | ||||
| Nephrolithiasis | 1.23 (1.10 to 1.37) | <0.001‡ | 1.18 (1.05 to 1.32) | 0.004‡ |
| Control | 1.00 | 1.00 | ||
| Age ≥60 years, women (n=11 860) | ||||
| Nephrolithiasis | 1.18 (1.04 to 1.35) | 0.009‡ | 1.16 (1.02 to 1.32) | 0.024‡ |
| Control | 1.00 | 1.00 | ||
*Models stratified by age, sex, income and region of residence.
†Adjusted for obesity, smoking, alcohol consumption, fasting blood glucose, total cholesterol and Charlson Comorbidity Index scores.
‡Cox proportional hazards regression model, significance at p<0.05.